This inventor holds 1 USPTO granted patent. Top assignee: The University of New Mexico. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Tamara Roitbak: Innovator in Human Renal Stem Cells
Introduction
Tamara Roitbak is a prominent inventor based in Albuquerque, NM (US). She has made significant contributions to the field of regenerative medicine, particularly in the study of human renal stem cells. Her innovative work has the potential to advance our understanding of kidney function and disease.
Latest Patents
Tamara Roitbak holds a patent for her groundbreaking work on human renal stem cells. The patent describes methods for isolating these stem cells from the papillary region of the human kidney. It also outlines techniques for culturing, characterizing, and differentiating these cells, including identifying those that are positive for Nestin and CD133. This research opens new avenues for potential therapeutic applications, including the differentiation of these cells into neurons.
Career Highlights
Tamara Roitbak is affiliated with the University of New Mexico, where she conducts her research. Her work has garnered attention for its innovative approach to understanding kidney health and disease. With a focus on stem cell research, she is at the forefront of developing new methodologies that could lead to significant medical advancements.
Collaborations
Some of her notable coworkers include Angela Wandinger-Ness and Elsa G Romero. Their collaborative efforts contribute to the rich research environment at the University of New Mexico, fostering innovation and discovery in the field of stem cell research.
Conclusion
Tamara Roitbak's contributions to the field of human renal stem cells exemplify the impact of innovative research on medical science. Her work not only enhances our understanding of kidney function but also paves the way for future therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
